Search details
1.
SMARCA4 Loss and Mutated ß-Catenin Induce Proliferative Lesions in the Murine Embryonic Cerebellum.
J Neurosci
; 44(15)2024 Apr 10.
Article
in English
| MEDLINE | ID: mdl-38383496
2.
Brahma-related gene 1 has time-specific roles during brain and eye development.
Development
; 148(10)2021 05 15.
Article
in English
| MEDLINE | ID: mdl-34042968
3.
Classification of Brain Tumors by Nanopore Sequencing of Cell-Free DNA from Cerebrospinal Fluid.
Clin Chem
; 70(1): 250-260, 2024 01 04.
Article
in English
| MEDLINE | ID: mdl-37624932
4.
Simultaneous Brg1 Knockout and MYCN Overexpression in Cerebellar Granule Neuron Precursors Is Insufficient to Drive Tumor Formation but Temporarily Enhances their Proliferation and Delays their Migration.
Cerebellum
; 20(3): 410-419, 2021 Jun.
Article
in English
| MEDLINE | ID: mdl-33387268
5.
hGFAP-Positive Stem Cells Depend on Brg1 for Proper Formation of Cerebral and Cerebellar Structures.
Cereb Cortex
; 30(3): 1382-1392, 2020 03 14.
Article
in English
| MEDLINE | ID: mdl-31504276
6.
The basic helix-loop-helix transcription factor TCF4 impacts brain architecture as well as neuronal morphology and differentiation.
Eur J Neurosci
; 51(11): 2219-2235, 2020 06.
Article
in English
| MEDLINE | ID: mdl-31919899
7.
TCF4 (E2-2) harbors tumor suppressive functions in SHH medulloblastoma.
Acta Neuropathol
; 137(4): 657-673, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30830316
8.
Malignant gliomas with H3F3A G34R mutation or MYCN amplification in pediatric patients with Li Fraumeni syndrome.
Acta Neuropathol
; 142(3): 591-593, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34264394
9.
Intraventricular SHH inhibition proves efficient in SHH medulloblastoma mouse model and prevents systemic side effects.
Neuro Oncol
; 26(4): 609-622, 2024 04 05.
Article
in English
| MEDLINE | ID: mdl-37767814
10.
Mean global DNA methylation serves as independent prognostic marker in IDH-wildtype glioblastoma.
Neuro Oncol
; 26(3): 503-513, 2024 03 04.
Article
in English
| MEDLINE | ID: mdl-37818983
11.
hGFAP-mediated GLI2 overexpression leads to early death and severe cerebellar malformations with rare tumor formation.
iScience
; 26(9): 107501, 2023 Sep 15.
Article
in English
| MEDLINE | ID: mdl-37608807
12.
MYC overexpression and SMARCA4 loss cooperate to drive medulloblastoma formation in mice.
Acta Neuropathol Commun
; 11(1): 174, 2023 11 02.
Article
in English
| MEDLINE | ID: mdl-37919824
13.
The tumor suppressor CREBBP and the oncogene MYCN cooperate to induce malignant brain tumors in mice.
Oncogenesis
; 12(1): 36, 2023 Jul 05.
Article
in English
| MEDLINE | ID: mdl-37407554
14.
G2 checkpoint targeting via Wee1 inhibition radiosensitizes EGFRvIII-positive glioblastoma cells.
Radiat Oncol
; 18(1): 19, 2023 Jan 29.
Article
in English
| MEDLINE | ID: mdl-36709315
15.
Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signatures.
Nat Commun
; 14(1): 7717, 2023 Nov 24.
Article
in English
| MEDLINE | ID: mdl-38001143
16.
An extracellular vesicle-related gene expression signature identifies high-risk patients in medulloblastoma.
Neuro Oncol
; 23(4): 586-598, 2021 04 12.
Article
in English
| MEDLINE | ID: mdl-33175161
17.
The transcriptional coactivator and histone acetyltransferase CBP regulates neural precursor cell development and migration.
Acta Neuropathol Commun
; 7(1): 199, 2019 12 05.
Article
in English
| MEDLINE | ID: mdl-31806049
18.
Generation of new transgenic SMARCA4-deficient mouse models results in neuromuscular weakness and paralysis of limbs.
Brain Pathol
; 33(3): e13146, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36582072
19.
Opposing Effects of CREBBP Mutations Govern the Phenotype of Rubinstein-Taybi Syndrome and Adult SHH Medulloblastoma.
Dev Cell
; 44(6): 709-724.e6, 2018 03 26.
Article
in English
| MEDLINE | ID: mdl-29551561
20.
The target landscape of clinical kinase drugs.
Science
; 358(6367)2017 12 01.
Article
in English
| MEDLINE | ID: mdl-29191878
Results
1 -
20
de 20
1
Next >
>>